ClinicalTrials.Veeva

Menu

Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles

A

Ain Shams University

Status

Active, not recruiting

Conditions

Male Infertility

Treatments

Procedure: Second Ejaculate for ICSI
Procedure: First Ejaculate for ICSI

Study type

Interventional

Funder types

Other

Identifiers

NCT07056400
Sci1312408001

Details and patient eligibility

About

The Aim of the trial:

Assess if a consecutive second ejaculate contains an equal, or even higher number of motile sperm and produces high-quality sperm for intracytoplasmic sperm injection (ICSI) in male factor patients and if it will improve clinical outcomes, such as fertilization rate, embryo quality, number of blastocysts retrieved per cycle, implantation, and hopefully pregnancy rates.

Full description

Background:

According to research, the length of abstinence has an impact on sperm DNA fragmentation (SDF) as well as sperm parameters. Long abstinence period increases the volume of semen and the concentration of sperm, but it will negatively impact motility, viability, and morphology.

The second ejaculation of males shows a considerable improvement in total motility and a significant decrease in (SDF) when it is collected within 1 to 3 hours of the first ejaculate.

it is essential to ensure the availability of high-quality spermatozoa with second ejaculation to enhance clinical results in ICSI cycles

Enrollment

108 estimated patients

Sex

Male

Ages

25 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male: with abnormal semen parameter according to WHO.
  • Age range between 25-45 for both partners.

Exclusion criteria

  • Female with factors that might affect Oocyte quality:

Polycystic ovary (PCO). Poor ovarian reserve. Endometriosis.

- Male partners who need testicular biopsy to retrieve sperms.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

108 participants in 2 patient groups

first ejaculate
Experimental group
Description:
In this arm, participants will undergo ICSI using sperm collected from the first ejaculate. Semen analysis will be conducted to assess sperm quality, including motility, morphology, and concentration. This arm will serve as the baseline for comparison with the second ejaculate arm.
Treatment:
Procedure: First Ejaculate for ICSI
Second Ejaculate
Experimental group
Description:
Participants in this arm will undergo ICSI using sperm collected from the second ejaculate, which will be obtained within a short interval (1-2 hours) after the first. Semen analysis will be conducted to compare sperm quality with that of the first ejaculate, and fertilization and embryo development outcomes will be evaluated
Treatment:
Procedure: Second Ejaculate for ICSI

Trial contacts and locations

1

Loading...

Central trial contact

Dr.Marwan Osama Elkady, Associate professor; Maram Magdy Elbasiony, Master's student

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems